Top Tweets for #gynOnc
Weโre looking forward to bringing you FOUR state of the art sessions at ESGO 2027!
For example, donโt miss the session on the ESGO-ESTRO-ESP Cervical Cancer Guidelines Update on 27 Feb.
Registration is open ๐https://t.co/XOokwuhMta
#gynonc #ESGO2027 #EndCervicalCancer

@MilenaMayorga Thank you @MilenaMayorga being such a fierce advocate for cancer prevention specifically #cervicalcancer by administration of #HPV vaccines to all boys and girls. #CervicalCancerEliminationDay @GynMe4 @IJGConline @IGCSociety #GynOnc
NRG-GY006 (2025; 448 eligible): Adding triapine to cisplatin chemoradiation for locally advanced cervical/vaginal cancer did not improve OS (HR 1.018, 95% CI 0.634-1.635) or PFS (HR 1.021). Median follow-up 28 months. No proven benefit. #GynOnc #CervicalCancer #ClinicalTrials

Great kickoff ๐ซ @RMWenham at our @MoffittGYNONC annual faculty RETREAT discussing the #rights to win ๐ฅand strategic best practices as #leaders in women's health and #GynOnc!๐๐๐
@MoffittNews
@DrMarkham
@JeannieChern
@ErinGeorgeMD #GeorgeLab

๐ฅ Who is a candidate for minimally invasive gynecologic cancer surgery? Merieme Klobocista, MD, of @HMHNewJersey breaks down surgical history, body habitus, and disease burden, plus how robotics has helped. ๐ค #GynOnc #RoboticSurgery
WATCH: https://t.co/WUxtRcxUOp
Join us for #ResidentJournalClub as we discuss the PORTEC-4a study and examine how molecular classification is shaping risk stratification and treatment decisions in early-stage endometrial cancer.
๐ https://t.co/B0UGIyv983 #radonc #brachytherapy #meded #gynonc

Bhavana Pothuri, MD (@nyulangone @Perlmutter_CC) discusses phase 3 TroFuse-005 data from #ESMO26, where sac-TMT improved PFS and OS vs chemotherapy in #EndometrialCancer.
๐ฅ WATCH: https://t.co/w1lzsOvrbK
#GynOnc #Oncology #CancerTreatment | @BPothuri

@ShannonWestin, MD, MPH (@UTMDAnderson) weighs in on B7-H4 ADCs in gynecologic cancers at #ESMO26, focusing on testing, toxicity in maintenance use, and sequencing amid resistance, target shifts, and expanding options.
๐ฅ WATCH: https://t.co/aoYdf7dtoF
#GynOnc #Oncology #Cancer

๐ฌ The ADC sofetabart mipitecan showed efficacy and safety in #OvarianCancer, leading to selection of a phase 3 dose for the FRAmework-01 trial.
Read more: https://t.co/OdnFXgkF5J
#GynOnc #Oncology #CancerTreatment #CancerResearch
RAMP-201 (phase II): In 57 patients with previously treated KRAS-mutant recurrent low-grade serous ovarian cancer, avutometinib + defactinib achieved 44% confirmed ORR (95% CI 31โ58). US FDA accelerated approval: 8 May 2025. #GynOnc #OvarianCancer #Oncology

Master the gray areas of gynecologic oncology coding. Gain practical strategies for coding, documentation, reimbursement & denial prevention through real-world scenarios. Register for the SGO 2027 Annual Meeting and add this masterclass: https://t.co/Q4XtLqBrlK #GynOnc

๐ฌ The ADC rinatabart sesutecan showed efficacy regardless of FRฮฑ status in heavily pretreated platinum-resistant #OvarianCancer with a tolerable safety profile.
Read more: https://t.co/6emHuiNtCK
#GynOnc #Oncology #CancerTreatment
#newpubliction..#GynOnc #training #global #survey..@IJGConline @RadwaMohammad15
Q-GOAL study: quality in gynecologic oncology advancement for learning... https://t.co/X9cGd6sjvR
How can we make #brachytherapy more trauma-informed for our patients?
Excited to share our original study in @BrachyJournal on PTSD after cervical cancer brachy, a project Iโve worked on since M1. Proud to advance this conversation ๐ฉต
๐https://t.co/wSx0AW2kLr
#RadOnc #GynOnc

Where will you make your impact? SGO & FWC Volunteer Committee applications and SGO Board of Directors applications and nominations are now open. Help shape the future of gynecologic oncology.โฐ Deadline: Oct. 9 https://t.co/ijjVcRntvK #GynOnc

Last Seen Hashtags on Sotwe
FamedparasaBayan
Seen from United States
ministergrantrobertson
Seen from United States
allowflash
Seen from United States
nakedsister
Seen from Switzerland
ๆ้
denizliesc
Seen from Turkey
minichattt()* filter:videos
Seen from Brazil
randomchat
Seen from United States
rebeu
Seen from Belgium
Snapchattt
Seen from Argentina
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.5M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.3M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers




















